Literature DB >> 33741354

Structural and dynamic characterization of the C-terminal tail of ErbB2: Disordered but not random.

Louise Pinet1, Ying-Hui Wang2, Célia Deville3, Ewen Lescop4, Françoise Guerlesquin5, Ali Badache6, François Bontems7, Nelly Morellet4, Dominique Durand8, Nadine Assrir4, Carine van Heijenoort9.   

Abstract

ErbB2 (or HER2) is a receptor tyrosine kinase overexpressed in some breast cancers and associated with poor prognosis. Treatments targeting the receptor extracellular and kinase domains have greatly improved disease outcome in the last 20 years. In parallel, the structures of these domains have been described, enabling better mechanistic understanding of the receptor function and targeted inhibition. However, the ErbB2 disordered C-terminal cytoplasmic tail (CtErbB2) remains very poorly characterized in terms of structure, dynamics, and detailed functional mechanism. Yet, it is where signal transduction is triggered via phosphorylation of tyrosine residues and carried out via interaction with adaptor proteins. Here, we report the first description, to our knowledge, of the ErbB2 disordered tail at atomic resolution using NMR, complemented by small-angle x-ray scattering. We show that although no part of CtErbB2 has any fully populated secondary or tertiary structure, it contains several transient α-helices and numerous transient polyproline II helices, populated up to 20 and 40%, respectively, and low but significant compaction. The presence of some structural elements suggests, along the lines of the results obtained for EGFR (ErbB1), that they may have a functional role in ErbB2's autoregulation processes. In addition, the transient formation of polyproline II helices is compliant with previously suggested interactions with SH3 domains. All in all, our in-depth structural study opens perspectives in the mechanistic understanding of ErbB2.
Copyright © 2021 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33741354      PMCID: PMC8204338          DOI: 10.1016/j.bpj.2021.03.005

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  87 in total

Review 1.  SH3 domain ligand binding: What's the consensus and where's the specificity?

Authors:  Kalle Saksela; Perttu Permi
Journal:  FEBS Lett       Date:  2012-05-02       Impact factor: 4.124

2.  Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.

Authors:  Tomoyasu Ishikawa; Masaki Seto; Hiroshi Banno; Youichi Kawakita; Mami Oorui; Takahiko Taniguchi; Yoshikazu Ohta; Toshiya Tamura; Akiko Nakayama; Hiroshi Miki; Hidenori Kamiguchi; Toshimasa Tanaka; Noriyuki Habuka; Satoshi Sogabe; Jason Yano; Kathleen Aertgeerts; Keiji Kamiyama
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

3.  Kinetic advantage of intrinsically disordered proteins in coupled folding-binding process: a critical assessment of the "fly-casting" mechanism.

Authors:  Yongqi Huang; Zhirong Liu
Journal:  J Mol Biol       Date:  2009-09-10       Impact factor: 5.469

4.  A self-consistent description of the conformational behavior of chemically denatured proteins from NMR and small angle scattering.

Authors:  Pau Bernadó; Martin Blackledge
Journal:  Biophys J       Date:  2009-11-18       Impact factor: 4.033

5.  Prothymosin alpha: a biologically active protein with random coil conformation.

Authors:  K Gast; H Damaschun; K Eckert; K Schulze-Forster; H R Maurer; M Müller-Frohne; D Zirwer; J Czarnecki; G Damaschun
Journal:  Biochemistry       Date:  1995-10-10       Impact factor: 3.162

6.  Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations.

Authors:  L J Smith; K A Bolin; H Schwalbe; M W MacArthur; J M Thornton; C M Dobson
Journal:  J Mol Biol       Date:  1996-01-26       Impact factor: 5.469

7.  Conformational changes accompany phosphorylation of the epidermal growth factor receptor C-terminal domain.

Authors:  Nam Y Lee; John G Koland
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

8.  Structural basis for eliciting a cytotoxic effect in HER2-overexpressing cancer cells via binding to the extracellular domain of HER2.

Authors:  Christian Jost; Johannes Schilling; Rastislav Tamaskovic; Martin Schwill; Annemarie Honegger; Andreas Plückthun
Journal:  Structure       Date:  2013-10-03       Impact factor: 5.006

9.  Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site.

Authors:  Jenny Bostrom; Shang-Fan Yu; David Kan; Brent A Appleton; Chingwei V Lee; Karen Billeci; Wenyan Man; Franklin Peale; Sarajane Ross; Christian Wiesmann; Germaine Fuh
Journal:  Science       Date:  2009-03-20       Impact factor: 47.728

10.  The CCPN data model for NMR spectroscopy: development of a software pipeline.

Authors:  Wim F Vranken; Wayne Boucher; Tim J Stevens; Rasmus H Fogh; Anne Pajon; Miguel Llinas; Eldon L Ulrich; John L Markley; John Ionides; Ernest D Laue
Journal:  Proteins       Date:  2005-06-01
View more
  2 in total

1.  The relative binding position of Nck and Grb2 adaptors impacts actin-based motility of Vaccinia virus.

Authors:  Angika Basant; Michael Way
Journal:  Elife       Date:  2022-07-07       Impact factor: 8.713

Review 2.  Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.

Authors:  Louise Pinet; Nadine Assrir; Carine van Heijenoort
Journal:  Biomolecules       Date:  2021-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.